Literature DB >> 26528444

Arteriovenous Fistula Recirculation in Hemodialysis.

Shokouh Shayanpour1, Mohammad Faramarzi1.   

Abstract

Entities:  

Keywords:  Arteriovenous; Hemodialysis; Recirculation

Year:  2015        PMID: 26528444      PMCID: PMC4623609          DOI: 10.5812/numonthly.27474

Source DB:  PubMed          Journal:  Nephrourol Mon        ISSN: 2251-7006


× No keyword cloud information.
Dear Editor, Recently, with great interest we read the review article by Zeraati et al. entitled “A review article: access recirculation among end stage renal disease patients undergoing maintenance hemodialysis” in your most valuable journal (1). The author summarized some of observations about causes and clinical significance of arteriovenous (AV) fistula recirculation, techniques for accurate assessment and main source of pitfall in calculation of access recirculation (AR) (1). Hemodialysis AR occurs when the blood urea concentration in arterial line is lower than that of systemic circulation, indicating that dialyzed blood returning through the venous needle reenters the HD machine through the arterial needle (2). It is well established that periodic assessment of AR and early detection and treatment of this problem has an important effect in better management of hemodialysis (HD) patients (3-5). High degrees of AR reduce solute concentration gradients across the dialysis membrane during HD by mixing dialyzed blood with undialyzed blood and reduce the effective clearance of urea and adequacy of HD. Therefore, presence of AR among HD patients leads to significant inadequate dialysis in long-term, which is an important contributor to morbidity and mortality among these patients (6-11). It is also suggested that high degree of AR is one of the surrogate markers of AV fistula inflow problems and periodic assessment of AR can be used as a screening tool for early detection of this problem, which improves long-term AV fistula patency rates (12). However, it seems that periodic assessment of AR is a neglected issue and most HD centers do not measure AR in HD patients (4). The most common cause of AR is the presence of stenosis in venous side of the AV fistula, which restricts dialyzed blood venous outflow and the other common cause of AR is inadequate arterial blood flow rate because of AV fistula problems (3, 12). Improper needle placement by HD staff which is due to lack of familiarity with the access anatomy is another cause of backflow or AV fistula recirculation and therefore HD staff have to be educated about the role of close proximity and improper arterial and venous needles placement (13). An access diagram should be obtained from the surgeon who constructed the AV fistula for appropriate placement of arterial and venous needles by HD staff. The access anatomy can be determined by temporarily occluding the mid portion of AV fistula. After occluding the mid portion of AV fistula, the portion retaining a pulse is the arterial side and the other portion is the venous side of access (3, 12).
  12 in total

1.  Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

Authors:  Francesca Tentori; William C Hunt; Mark Rohrscheib; Min Zhu; Christine A Stidley; Karen Servilla; Dana Miskulin; Klemens B Meyer; Edward J Bedrick; H Keith Johnson; Philip G Zager
Journal:  J Am Soc Nephrol       Date:  2007-07-18       Impact factor: 10.121

Review 2.  Recirculation, a seemingly simple concept.

Authors:  D Schneditz
Journal:  Nephrol Dial Transplant       Date:  1998-09       Impact factor: 5.992

3.  Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey.

Authors:  Nicola Tessitore; Valeria Bedogna; Albino Poli; Antonella Impedovo; Francesco Antonucci; Teodoro Teodori; Antonio Lupo
Journal:  J Nephrol       Date:  2006 Mar-Apr       Impact factor: 3.902

4.  Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography.

Authors:  Seyed Seifollah Beladi Mousavi; Moshgan Sametzadeh; Fatemeh Hayati; Seyed Mahmoud Fatemi
Journal:  Iran J Kidney Dis       Date:  2010-07       Impact factor: 0.892

5.  Screening for subclinical stenosis in native vessel arteriovenous fistulae.

Authors:  Marcello Tonelli; Kailash Jindal; David Hirsch; Sandra Taylor; Christopher Kane; Susan Henbrey
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

6.  Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran.

Authors:  Seyed Seifollah Beladi-Mousavi; Mohammad Javad Alemzadeh-Ansari; Mohammad Hasan Alemzadeh-Ansari; Marzieh Beladi-Mousavi
Journal:  Iran J Kidney Dis       Date:  2012-11       Impact factor: 0.892

7.  Effect of intranasal DDAVP in prevention of hypotension during hemodialysis.

Authors:  Seyed S Beladi-Mousavi; Marzieh Beladi-Mousavi; Fatemeh Hayati; Mehdi Talebzadeh
Journal:  Nefrologia       Date:  2012       Impact factor: 2.033

8.  Outcome of patients on haemodialysis in Khuzestan, Iran.

Authors:  Seyed Seifollah Beladi Mousavi; Mohammad Javad Alemzadeh Ansari; Bahman Cheraghian
Journal:  NDT Plus       Date:  2011-04

Review 9.  Erythropoietin; a review on current knowledge and new concepts.

Authors:  Mohamad-Reza Tamadon; Seyed Seifollah Beladi-Mousavi
Journal:  J Renal Inj Prev       Date:  2013-10-10

10.  A review article: access recirculation among end stage renal disease patients undergoing maintenance hemodialysis.

Authors:  Abbasali Zeraati; Seyed Seifollah Beladi Mousavi; Marzieh Beladi Mousavi
Journal:  Nephrourol Mon       Date:  2013-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.